Table 4 Group I (n = 98): Sensitivity, specificity and accuracy for urinary URO17® and urine cytology
From: The role of URO17® in diagnosis and follow up of bladder cancer patients
Cystoscopy | Sensitivity | Specificity | PPV | NPV | Accuracy | ||||
|---|---|---|---|---|---|---|---|---|---|
Free of malignancy (n = 52) | Positive of malignancy (n = 46) | ||||||||
No. | % | No. | % | ||||||
Urinary URO17® | |||||||||
Negative | 50 | 96.0 | 0 | 0.0 | 100.0 | 96.15 | 95.83 | 100.0 | 97.96 |
Positive for malignancy | 2 | 3.8 | 46 | 100.0 | |||||
χ2 (P) | 90.304* (< 0.001*) | ||||||||
Urine cytology | |||||||||
Inflammatory | 26 | 50.0 | 4 | 8.7 | 91.30 | 50.0 | 61.76 | 86.67 | 69.39 |
Positive for malignancy | 26 | 50.0 | 42 | 91.3 | |||||
χ2 (P) | 19.604* (< 0.001*) | ||||||||